ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,584Medicare Part D Prescriptions Filled, Including Refills

Rank: 628 out of 2170

$379K Total Retail Price of All Prescriptions

Rank: 723 out of 2170

355 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 355 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 355 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 2,647 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 438 110 1 2
SIMVASTATIN 414 208 2 1
HYDROCODONE-ACETAMINOPHEN 352 114 S3 3 7
CITALOPRAM HBR 228 58 4 19
BENAZEPRIL-HYDROCHLOROTHIAZIDE 226 78 5 161
FUROSEMIDE 197 81 6 6
METFORMIN HCL 195 97 7 8
METOPROLOL TARTRATE 180 99 8 10
LEVOTHYROXINE SODIUM 169 96 9 5
PRAVASTATIN SODIUM 146 50 10 11
PROMETHAZINE HCL 137 13 R 11 70
GABAPENTIN 137 41 11 14
MELOXICAM 134 50 13 28
ZOLPIDEM TARTRATE 133 24 14 17
NEXIUM 129 34 15 22
PREDNISONE 122 27 16 41
BENAZEPRIL HCL 121 46 17 55
IBUPROFEN 113 11 18 105
CARISOPRODOL 108 0 R 19 111
AZITHROMYCIN 97 25 20 47
COMBIVENT 89 19 21 112
SUBOXONE 85 0 22 241
GLIPIZIDE 82 52 23 62
DOXEPIN HCL 81 29 24 202
AMLODIPINE BESYLATE 80 57 25 4
CYCLOBENZAPRINE HCL 79 0 R 26 52
ADVAIR DISKUS 78 18 27 45
ENDOCET 78 0 S2 27 106
SERTRALINE HCL 76 20 29 25
POTASSIUM CHLORIDE 76 37 29 16
CYMBALTA 74 15 31 44
OXYCODONE HCL-ACETAMINOPHEN 73 0 S2 32 74
AMITRIPTYLINE HCL 65 19 R 33 61
LISINOPRIL 64 0 34 3
CLOPIDOGREL 63 35 35 37
ATENOLOL 61 16 36 23
VENTOLIN HFA 59 0 37 102
HYDROCHLOROTHIAZIDE 58 41 38 9
TIZANIDINE HCL 57 12 39 123
LOVASTATIN 53 50 40 34
WARFARIN SODIUM 52 35 41 15
DICLOFENAC SODIUM 51 12 42 101
FLUOXETINE HCL 51 16 42 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.